Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025

Evaluation of patients diagnosed with primary Sjogren's syndrome with and without pulmonary involvement.

View Full Paper
Ask AI
Bookmark
Share

Authors

ZÖZehra ÖzsoyTÖTuğçe Şahin ÖzdemirelKEKerem Ensarıoğlu

Discussion

Loading...

Member takes

Overview

Analysis reveals differences in respiratory parameters and disease activity in patients with sjogren's syndrome and pulmonary involvement, highlighting diagnostic needs.

Key Points

  • Patients with sjogren's syndrome and pulmonary involvement had higher disease activity and immunosuppressive use.
  • Males with interstitial lung disease exhibited lower forced vital capacity values and more frequent auto-antibody positivity.
  • A multidisciplinary approach involving experts aims to improve diagnosis and management of pulmonary implications in sjogren's syndrome patients.
  • Pulmonary involvement in sjogren's syndrome significantly contributes to morbidity and mortality, demanding careful monitoring.

Cite This Study

Özsoy et al. (2025) studied this question.

synapsesocial.com/papers/68e02f2cf0e39f13e7fa1f0fhttps://doi.org/10.36141/svdld.v42i3.17364
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1[Research status of diagnosis, treatment and prognosis of primary Sjögren's syndrome-associated interstitial lung disease].2025
  2. 2Clinical Characteristics and Risk Factors for Progressive Pulmonary Fibrosis in Primary Sjögren’s Syndrome: A Case-Control Study2025
  3. 3The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung disease2025
  4. 4Neurological involvement in primary Sjögren’s syndrome: a retrospective analysis of clinical, radiological, laboratory and therapeutic correlations2025
  5. 5Comparison between clinical and immunological features of scleroderma with and without interstitial lung disease2025